Global Veterinary Diagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Animal Type;
Production, and Companion.By End Use;
Reference Laboratories, and Veterinarians.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Veterinary Diagnostics Market (USD Million), 2021 - 2031
In the year 2023, the Global Veterinary Diagnostics Market was valued at USD 6,452.94 million. The size of this market is expected to increase to USD 12,841.41 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 10.3%.
Veterinary diagnostics encompass a wide range of tests, procedures, and imaging modalities designed to detect, monitor, and manage various diseases and conditions affecting companion animals, livestock, and exotic species. These diagnostics play a crucial role in guiding treatment decisions, monitoring disease progression, and ensuring the overall health and welfare of animals under veterinary care.
With the increasing prevalence of infectious diseases, chronic conditions, and age-related ailments among animals, the demand for advanced diagnostic solutions has surged. Veterinary diagnostics encompass a broad spectrum of methodologies, including clinical pathology, microbiology, molecular diagnostics, immunodiagnostics, and imaging techniques such as radiography, ultrasonography, and magnetic resonance imaging (MRI). These tools enable veterinarians to accurately diagnose a wide range of health issues, from common ailments like parasitic infections and respiratory diseases to complex conditions such as cancer and organ dysfunction.
Technological advancements have revolutionized the field of veterinary diagnostics, with the development of rapid point-of-care testing devices, advanced laboratory analyzers, and innovative imaging technologies. These advancements have not only improved diagnostic accuracy and efficiency but have also expanded access to diagnostic services in remote and underserved areas, ensuring that animals receive timely and effective care regardless of geographical location.
Global Veterinary Diagnostics Market Recent Developments
-
In June 2023,Mars, Inc. completed the acquisition of Heska by merging it into its Petcare Science & Diagnostics division. This expanded its portfolio.
-
In June 2023, IDEXX launched the first test for detecting kidney injury in cats and dogs called the IDEXX Cystatin B Test.
-
In December 2021, PetDx- specializing in liquid biopsy for pets, raised about USD 62 million in series B funding. This enabled the company to expand the implementation of its liquid biopsy test for cancer detection in dogs called OncoK9 and to increase testing at its central laboratory in San Diego.
Segment Analysis
The Global Veterinary Diagnostics Market is segmented by Animal Type, including Companion Animals, Livestock, and Other Animals. The Companion Animals segment, which includes pets like dogs, cats, and small mammals, holds a significant share of the market. Rising pet adoption, increasing awareness about animal health, and higher spending on veterinary care are driving demand in this segment. The Livestock segment, comprising cattle, poultry, sheep, and other farm animals, is also a key part of the market, driven by the need for disease management and prevention to ensure food safety and the health of the animals. Other Animals, such as exotic pets and horses, represent a smaller but growing segment of the market, particularly in regions with higher disposable income and advanced veterinary care.
The End-Use segment of the Veterinary Diagnostics Market includes Veterinary Clinics, Diagnostic Laboratories, Research Institutes, and Others. Veterinary Clinics are the largest end-users of veterinary diagnostics, as they provide direct healthcare services to animals and often rely on diagnostic tools for treatment. Diagnostic Laboratories serve as another major segment, offering more advanced diagnostic testing and often working with veterinary clinics. The Research Institutes segment includes institutions conducting studies on animal diseases and healthcare, utilizing diagnostic tools to analyze and develop better treatments. The Others category includes animal shelters, zoos, and other establishments requiring diagnostic services for a variety of animals.
Geographically, the Veterinary Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market due to the high level of awareness about animal health, the presence of advanced veterinary healthcare systems, and a growing trend of pet ownership. Europe follows, with robust demand for veterinary diagnostic tools driven by stringent animal health regulations, as well as a large population of both pets and livestock. In the Asia Pacific region, the market is seeing rapid growth as pet ownership rises and more focus is placed on livestock health. Latin America and the Middle East & Africa are emerging markets, with steady growth due to increased healthcare investments in veterinary practices, although the market growth is somewhat slower compared to North America and Europe.
Global Veterinary Diagnostics Segment Analysis
In this report, the Global Veterinary Diagnostics Market has been segmented by Animal Type, End Use and Geography.
Global Veterinary Diagnostics Market, Segmentation by Animal Type
The Global Veterinary Diagnostics Market has been segmented by Animal Type into Production and Companion.
Diagnostic tests for production animals focus on monitoring herd health, detecting infectious diseases, optimizing production efficiency, and ensuring food safety and quality assurance. Common diagnostic procedures in production animal medicine include serological testing for infectious diseases, microbiological culture and sensitivity testing, molecular diagnostics for genetic screening, and imaging modalities such as ultrasonography for reproductive management. The goal of production animal diagnostics is to enhance productivity, minimize economic losses due to disease outbreaks, and safeguard public health by preventing the spread of zoonotic diseases through the food supply chain.
The Companion category encompasses household pets, including dogs, cats, horses, and exotic companion animals. Companion animal diagnostics serve a broader range of purposes, including preventive care, disease diagnosis, treatment monitoring, and wellness management. Diagnostic tests for companion animals encompass a wide range of modalities, including routine bloodwork, urinalysis, fecal analysis, imaging studies (e.g., radiography, ultrasonography), cytology, histopathology, and advanced molecular diagnostics. These tests aid in the diagnosis and management of various conditions, including infectious diseases, metabolic disorders, endocrine imbalances, cancer, and degenerative diseases. Companion animal diagnostics play a crucial role in supporting veterinary practitioners in providing high-quality healthcare and personalized treatment plans for their patients.
Global Veterinary Diagnostics Market, Segmentation by End Use
The Global Veterinary Diagnostics Market has been segmented by End Use into Reference Laboratories and Veterinarians.
Reference Laboratories serve as centralized facilities equipped with advanced diagnostic equipment and staffed by specialized professionals, including veterinary pathologists, microbiologists, and clinical chemists. These laboratories offer a comprehensive range of diagnostic tests and services, including clinical pathology, microbiology, molecular diagnostics, cytology, histopathology, and imaging studies. Reference laboratories provide specialized expertise and resources that may not be readily available in individual veterinary clinics, enabling veterinarians to access advanced diagnostic tools, interpret complex test results, and obtain second opinions for challenging cases. Additionally, reference laboratories contribute to research and surveillance efforts, monitor disease trends, and provide epidemiological data to support public health initiatives.
Veterinarians represent the frontline providers of veterinary diagnostic services, delivering personalized care to animals in clinical practice settings such as veterinary clinics, hospitals, and mobile veterinary units. Veterinary practitioners rely on diagnostic tests to assess the health status of their patients, formulate differential diagnoses, and develop treatment plans tailored to individual patient needs. Diagnostic tests performed by veterinarians encompass a wide range of modalities, including physical examinations, laboratory tests (e.g., bloodwork, urinalysis, fecal analysis), imaging studies (e.g., radiography, ultrasonography), and point-of-care testing (e.g., rapid antigen tests, glucose monitoring). By integrating diagnostic information with clinical observations and patient history, veterinarians provide comprehensive care and improve health outcomes for their patients.
Global Veterinary Diagnostics Market, Segmentation by Geography
In this report, the Global Veterinary Diagnostics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Veterinary Diagnostics Market Share (%), by Geographical Region, 2024
North America, as a mature market, boasts advanced veterinary healthcare infrastructure, high pet ownership rates, and stringent regulations regarding food safety and animal health. This region leads in the adoption of innovative diagnostic technologies and services, driven by the growing demand for preventive care and wellness programs for companion animals.
Europe follows suit, characterized by a strong veterinary diagnostics industry supported by robust research and development activities, sophisticated laboratory facilities, and a well-established regulatory framework. The region's emphasis on sustainable agriculture and animal welfare further fuels market growth, with a focus on ensuring the safety and quality of animal-derived food products.
The Asia Pacific region emerges as a rapidly growing market, propelled by increasing pet ownership rates, rising disposable incomes, and expanding veterinary healthcare infrastructure across emerging economies. With a large population of production animals and growing concerns about food safety and security, the demand for veterinary diagnostics in Asia Pacific is driven by the need to monitor and manage infectious diseases, ensure livestock health, and meet regulatory standards.
The Middle East and Africa region presents unique opportunities and challenges, characterized by a diverse landscape of animal agriculture, varying levels of veterinary healthcare access, and evolving regulatory environments. While pet ownership rates are rising in urban centers, the region's agricultural sector drives demand for veterinary diagnostics to support livestock production and ensure food security.
Latin America exhibits significant growth potential, fueled by a burgeoning pet population, increasing awareness of companion animal health, and expanding investment in veterinary healthcare infrastructure. The region's diverse ecosystems and agricultural landscapes create opportunities for veterinary diagnostics to address a wide range of animal health challenges, from infectious diseases to nutritional deficiencies.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Veterinary Diagnostics Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Pet Ownership Rates
- Growing Demand for Food Safety and Quality Assurance
-
Rising Prevalence of Zoonotic Diseases - The emergence and reemergence of zoonotic diseases such as avian influenza, rabies, brucellosis, leptospirosis, and Lyme disease underscore the critical importance of early detection and surveillance in both animal and human populations. Veterinary diagnostics play a crucial role in identifying infected animals, tracing the spread of disease within animal populations, and implementing control measures to prevent transmission to humans. Timely diagnosis and intervention are essential for containing zoonotic disease outbreaks, mitigating their impact on animal health, human health, and the economy.
The One Health approach, which recognizes the interconnectedness of human, animal, and environmental health, has gained traction in recent years, driving collaborative efforts between veterinary and public health sectors to address zoonotic disease threats comprehensively. Veterinary diagnostics serve as a cornerstone of the One Health framework, facilitating early detection, surveillance, and response to zoonotic disease events at the human-animal interface.
Restraints
- High Cost of Advanced Diagnostic Technologies
- Limited Access to Veterinary Diagnostic Services in Rural Areas
-
Regulatory Hurdles and Compliance Requirements - Compliance with regulatory requirements involves navigating a complex maze of pre-market approvals, product registrations, quality assurance standards, and post-market surveillance obligations. Veterinary diagnostic companies must invest significant time, resources, and expertise to navigate the regulatory pathway and obtain necessary approvals for their products to enter the market. This process can be time-consuming and costly, particularly for novel diagnostic technologies or products intended for multiple jurisdictions with differing regulatory requirements.
Regulatory hurdles may pose challenges for veterinary diagnostic companies seeking to introduce innovative technologies or expand their product portfolios. Strict regulatory requirements for clinical validation, analytical performance evaluation, and safety testing may prolong the time-to-market for new diagnostic products, delaying their availability to veterinary practitioners and patients. Additionally, variations in regulatory standards across different regions or countries may necessitate separate regulatory submissions and compliance efforts, further complicating market entry and expansion strategies.
Changes in regulatory requirements or enforcement policies can disrupt existing business operations and impose additional burdens on veterinary diagnostic companies. Adapting to evolving regulatory landscapes may require companies to invest in continuous regulatory monitoring, compliance training, and organizational restructuring to ensure ongoing adherence to regulatory standards.
Opportunities
- Expansion of Point-of-Care Testing Solutions
- Adoption of Telemedicine and Remote Monitoring Technologies
-
Development of Multiplex Assay Platforms for Comprehensive Testing - Multiplex assay platforms enable the simultaneous detection and quantification of multiple analytes within a single sample, offering advantages such as increased throughput, reduced sample volume requirements, and enhanced efficiency compared to traditional singleplex assays.
One key advantage of multiplex assay platforms is their ability to deliver comprehensive testing for a wide range of analytes, including pathogens, biomarkers, and genetic markers, in a single assay run. This enables veterinarians to obtain a more comprehensive picture of an animal's health status and disease profile, facilitating more accurate diagnosis, prognosis, and treatment planning. For example, multiplex assays can simultaneously detect multiple infectious agents responsible for complex disease syndromes, such as respiratory or gastrointestinal infections in livestock or companion animals, enabling targeted antimicrobial therapy and disease management strategies.
Multiplex assay platforms offer versatility and flexibility in assay design, allowing customization to address specific diagnostic needs and disease priorities in different animal species and healthcare settings. By incorporating a diverse array of analytes relevant to veterinary medicine, multiplex assays can support a wide range of diagnostic applications, including infectious disease surveillance, vaccine development, genetic screening, and monitoring of therapeutic responses. This versatility enables veterinarians to tailor diagnostic approaches to individual patient needs, optimize resource allocation, and improve clinical decision-making.
Competitive Landscape Analysis
Key players in Global Veterinary Diagnostics Market include:
- Agrolabo S.p.A
- Embark Veterinary Inc
- Esaote SPA
- Thermo Fisher Scientific Inc
- Innovative Diagnostics SAS
- Virbac
- FUJIFILM Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Animal Type
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Veterinary Diagnostics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Pet Ownership Rates
-
Growing Demand for Food Safety and Quality Assurance
-
Rising Prevalence of Zoonotic Diseases
-
- Restraints
-
High Cost of Advanced Diagnostic Technologies
-
Limited Access to Veterinary Diagnostic Services in Rural Areas
-
Regulatory Hurdles and Compliance Requirements
-
- Opportunities
-
Expansion of Point-of-Care Testing Solutions
-
Adoption of Telemedicine and Remote Monitoring Technologies
-
Development of Multiplex Assay Platforms for Comprehensive Testing
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Veterinary Diagnostics Market, By Animal Type, 2021 - 2031 (USD Million)
-
Production
-
Companion
-
- Global Veterinary Diagnostics Market, By End Use, 2021 - 2031 (USD Million)
-
Reference Laboratories
-
Veterinarians
-
- Global Veterinary Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Veterinary Diagnostics Market, By Animal Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Agrolabo S.p.A
- Embark Veterinary Inc
- Esaote SPA
- Thermo Fisher Scientific Inc
- Innovative Diagnostics SAS
- Virbac
- FUJIFILM Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market